These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38214270)

  • 1. Mechanism-Based Inactivation of CYP2D6 by Phellopterin and Related Drug-Drug Interaction with Metoprolol.
    Cheng Z; He Y; Chen Y; Zhao G; Liu Y; Zhang J; Li X; Ran G; Zhang Q; Peng Y; Li W; Zheng J
    J Agric Food Chem; 2024 Jan; 72(3):1745-1755. PubMed ID: 38214270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease.
    Rabinovich-Guilatt L; Steiner L; Hallak H; Pastino G; Muglia P; Spiegelstein O
    Br J Clin Pharmacol; 2017 Oct; 83(10):2214-2224. PubMed ID: 28449367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition.
    Long T; Cristofoletti R; Cicali B; Michaud V; Dow P; Turgeon J; Schmidt S
    J Clin Pharmacol; 2022 Jan; 62(1):76-86. PubMed ID: 34383318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition.
    Athukuri BL; Neerati P
    Drug Metab Pers Ther; 2016 Dec; 31(4):229-234. PubMed ID: 27875319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6.
    Zhang K; Li Y; Fu Y; Cui T; Wang Q; Mao X; Peng Y; Zheng J
    Curr Drug Metab; 2021; 22(11):882-892. PubMed ID: 34191696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lotus leaf alkaloid fraction can strongly inhibit CYP2D6 isoenzyme activity.
    Ye LH; Kong LT; Yan MZ; Cao FR; Wang LS; Liao YH; Pan RL; Chang Q
    J Ethnopharmacol; 2016 Dec; 194():913-917. PubMed ID: 27771456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL; Suri A
    Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
    Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
    Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitidine Chloride Is a Mechanism-Based Inactivator of CYP2D6.
    Mao X; Hu Z; Wang Q; Zhang N; Zhou S; Peng Y; Zheng J
    Drug Metab Dispos; 2018 Aug; 46(8):1137-1145. PubMed ID: 29773554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanfu base A, an antiarrhythmic alkaloid of Aconitum coreanum, Is a CYP2D6 inhibitor of human, monkey, and dog isoforms.
    Sun J; Peng Y; Wu H; Zhang X; Zhong Y; Xiao Y; Zhang F; Qi H; Shang L; Zhu J; Sun Y; Liu K; Liu J; A J; Ho RJ; Wang G
    Drug Metab Dispos; 2015 May; 43(5):713-24. PubMed ID: 25681130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the CYP2D6 and CYP3A4 inhibition potential of metoprolol metabolites and their contribution to drug-drug and drug-herb interaction by LC-ESI/MS/MS.
    Borkar RM; Bhandi MM; Dubey AP; Ganga Reddy V; Komirishetty P; Nandekar PP; Sangamwar AT; Kamal A; Banerjee SK; Srinivas R
    Biomed Chromatogr; 2016 Oct; 30(10):1556-72. PubMed ID: 27006091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Astragaloside IV on the Pharmacokinetics of Metoprolol in Rats and its Mechanism.
    Shi Z; Jiang J; Zhao D; Xie B; Li Y; Yu C
    Curr Drug Metab; 2022; 23(2):131-136. PubMed ID: 35088663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inactivation of cytochrome P450 2D6 by chelidonine.
    Liu Y; Cui T; Peng Y; Ji M; Zheng J
    J Biochem Mol Toxicol; 2019 Feb; 33(2):e22251. PubMed ID: 30368994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol.
    Krauwinkel W; Dickinson J; Schaddelee M; Meijer J; Tretter R; van de Wetering J; Strabach G; van Gelderen M
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):43-52. PubMed ID: 23728524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity.
    Hamelin BA; Bouayad A; Méthot J; Jobin J; Desgagnés P; Poirier P; Allaire J; Dumesnil J; Turgeon J
    Clin Pharmacol Ther; 2000 May; 67(5):466-77. PubMed ID: 10824625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.
    Damy T; Pousset F; Caplain H; Hulot JS; Lechat P
    Fundam Clin Pharmacol; 2004 Feb; 18(1):113-23. PubMed ID: 14748763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic model incorporating mechanism-based inactivation of CYP2D6 can explain both non-linear kinetics and drug interactions of paroxetine.
    Mikami A; Ohtani H; Hori S; Sawada Y
    Int J Clin Pharmacol Ther; 2013 May; 51(5):374-82. PubMed ID: 23357843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia.
    Wang Y; Zhou L; Dutreix C; Leroy E; Yin Q; Sethuraman V; Riviere GJ; Yin OQ; Schran H; Shen ZX
    Br J Clin Pharmacol; 2008 Jun; 65(6):885-92. PubMed ID: 18384443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.
    Cho DY; Bae SH; Lee JK; Park JB; Kim YW; Lee S; Oh E; Kim BT; Bae SK
    Xenobiotica; 2015 Mar; 45(3):256-63. PubMed ID: 25268386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib.
    Qiu X; Ren B; Lian Y; Fang L; Dong Z
    J Oncol Pharm Pract; 2023 Jun; 29(4):1002-1005. PubMed ID: 36380705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.